FIELD: medicine.
SUBSTANCE: method involves applying biphosphonates for producing preparations and treating osteoblastic (osteosclerotic) metastases connected with prostate cancer.
EFFECT: enhanced effectiveness in inhibiting abnormal osteoblast proliferation.
5 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLYING BIS-PHOSPHONIC ACIDS FOR TREATMENT OF ANGIOGENESIS | 2000 |
|
RU2261100C2 |
| APPLICATION OF ZOLEDRONE ACID, ITS SALTS, HYDRATES AND METHOD OF ANTINOCICEPTIVE OR ANTIALLODYNIC TREATMENT OF PAIN, METHOD OF NEUROTIC PAIN TREATMENT | 2001 |
|
RU2325913C2 |
| COMBINATIONS INCLUDING EPOTHILONES, AND THEIR PHARMACEUTICAL APPLICATION | 2002 |
|
RU2375058C2 |
| PHARMACEUTICAL COMPOSITION FOR USING IN THERAPY OF MALIGNANT NEOPLASM COMPRISING COMBINATION OF BISPHOSPHONATE, COX-2 INHIBITOR AND TAXOL | 2002 |
|
RU2317819C2 |
| RADIOPHARMACEUTICAL AGENT FOR DIAGNOSING OR TREATING (THERAPY) SKELETAL BONE INJURIES AND METHOD OF PREPARING SAID AGENT | 2008 |
|
RU2407746C2 |
| METHOD FOR INTRODUCING BISPHOSPHONATES | 2001 |
|
RU2288722C2 |
| COMPOSITION COMPRISING N-{5-[4-(4-METHYLPIPERAZINOMETHYL)BENZOYLAMIDO]-2-METHYLPHENYL}-4-(3-PYRILYL)-2-PYRIDINEAMINE AND CHEMOTHERAPEURIC AGENT | 2002 |
|
RU2318517C2 |
| METHOD OF TREATMENT OF PATIENT WITH OSTEOLYTIC METASTASIS | 1999 |
|
RU2153358C1 |
| COMPLEX COMPOUNDS CONTAINING RADIONUCLIDE Th, AS WELL AS BISPHOSPHONATE FRAGMENT, METHODS FOR THEIR PRODUCTION, AS WELL AS POTENTIAL USE AS ACTIVE SUBSTANCE IN COMPOSITION OF OSTEOTROPIC RADIOPHARMACEUTICAL DRUG | 2020 |
|
RU2767567C1 |
| METHOD OF TREATING PATIENTS WITH METASTASES IN LYMPH NODES AND OLIGOMETASTATIC DISEASE IN BONES OF SKELETON IN PROSTATE CANCER | 2018 |
|
RU2695348C2 |
